TenNor Therapeutics Competitors and Similar CompaniesClear all
TenNor Therapeutics's competitors and similar companies include Eikon Therapeutics, IMPACT Therapeutics and Chipscreen Biosciences.
 TenNor Therapeutics TenNor Therapeutics (丹诺医药是 ) is a company focusing on the research and development of drugs to address unmet medical needs in the area of infectious diseases. |  Eikon Therapeutics Eikon Therapeutics is a biopharmaceutical company that provides a method of drug discovery based on tracking and measuring the movement of individual proteins in live cells. |  IMPACT Therapeutics PACT Therapeutics (英派药业) is a biopharmaceutical company engaged in the discovery and development of therapeutics to treat cancer. |  Chipscreen Biosciences Shenzhen Chipscreen Biosciences (微芯生物) is biotech company engaged in research and development of small-molecule drugs. | |
Founding Date | Founding Date 2013 | Founding Date 2019 | Founding Date 2009 | Founding Date 2001 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Suzhou Shi, CN HQ | Locations Millbrae, US HQ Hayward, US Jersey City, US New York, US | Locations CN HQ Nanjing Shi, CN | Locations HQ |
Employees | Employees 21 | Employees 384 | Employees 4 | Employees 371 |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 665.8m | Total funding raised $ 40m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Eikon Therapeutics
HQ
Millbrae, US
Employees
384
Eikon Therapeutics is a biopharmaceutical company that provides a method of drug discovery based on tracking and measuring the movement of individual proteins in live cells.
View companyIMPACT Therapeutics
HQ
CN
Employees
4
PACT Therapeutics (英派药业) is a biopharmaceutical company engaged in the discovery and development of therapeutics to treat cancer.
View companyChipscreen Biosciences
HQ
Employees
371
Shenzhen Chipscreen Biosciences (微芯生物) is biotech company engaged in research and development of small-molecule drugs.
View company